Eleven Biotherapeutics (EBIO) Gains Ahead of Q4 Earnings

Eleven Biotherapeutics Inc (NASDAQ: EBIO) shares hiked 6.8% to $2.03, as the company is expected to report earnings for its fourth quarter. Share volume totaled 2.7 million, compared to an all-day average of 437,000